Stay updated on Canakinumab with Docetaxel in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.

Latest updates to the Canakinumab with Docetaxel in NSCLC: Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added, replacing v3.3.3. This appears to be a minor site update with no substantive changes to the trial information on the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Revision: v3.3.3 to the Record History. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check54 days agoChange DetectedThe Record History now shows a new revision entry Revision: v3.3.2 and the older Revision: v3.2.0 entry is removed. This update affects only the history metadata of the page, not the core trial information.SummaryDifference0.0%

- Check61 days agoChange DetectedDifference0.3%

- Check83 days agoChange DetectedVersion 74 (posted 2023-08-16) updates the Study Status and Adverse Events sections. It also notes that Quality Control Review has not concluded.SummaryDifference0.0%

- Check104 days agoChange DetectedMajor change: page now advertises a government operating status notice and updates the release version to v3.2.0; previous v3.1.0 label was removed.SummaryDifference7%

Stay in the know with updates to Canakinumab with Docetaxel in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canakinumab with Docetaxel in NSCLC: Clinical Trial page.